Related Experiment Videos
[A scale for evaluating withdrawal symptoms induced by anxiolytic agents]
1Service de Pharmacologie Clinique, C.H.U., Nantes.
L'Encephale
|July 1, 1988
Summary
A new scale helps differentiate anxiety symptoms from tranquilizer withdrawal syndrome (TWS). This validated tool assesses various physical and psychological symptoms, aiding accurate diagnosis and treatment.
Area of Science:
- Psychopharmacology
- Clinical Psychology
- Medical Sociology
Context:
- Tranquilizer use can lead to complex withdrawal syndromes.
- Distinguishing withdrawal symptoms from anxiety is clinically significant.
- Existing assessment tools may lack specificity for tranquilizer withdrawal.
Purpose:
- To introduce and validate a scale for assessing tranquilizer withdrawal syndrome (TWS).
- To differentiate symptoms specifically related to tranquilizer cessation from generalized anxiety.
- To provide a standardized instrument for clinical evaluation.
Summary:
- A scale was developed and validated to evaluate tranquilizer withdrawal syndrome (TWS).
- The scale identifies common symptoms such as fatigue, headache, vertigo, and tremor.
- It aims to distinguish between anxiety-induced and withdrawal-induced symptoms.
Impact:
- Facilitates more accurate diagnosis of tranquilizer dependence and withdrawal.
- Supports tailored treatment strategies for patients experiencing TWS.
- Enhances clinical understanding of benzodiazepine and related drug withdrawal effects.